Herborium Group enters $300 billion plus mobile sales market;

Expands Its Presence in Rapidly Growing French Market

August 21, 2014 09:13 ET | Source:Herborium Group, Inc.

Fort Lee, New Jersey, Aug. 21, 2014 (GLOBE NEWSWIRE) -- Herborium® Group, Inc.
(OTC Pink: HBRM),
www.Herborium.com, a
Botanical Therapeutics® Company and the provider of unique
all botanical medicinal products (Botanical
Therapeutics®) that target dermatological problems such as acne,
and other health and wellness concerns in the areas of sexual
performance as well as energy depletion and stress, has
successfully deployed a responsive design e-commerce infrastructure
and joined $300 billion plus mobile market.

During first two months of new system operation Herborium mobile
sales grew 25%. Since Herborium sales for the first seven
months of 2014 has surpassed the sales realized in the entire year
of 2013this rapid growth reaffirms the present run rate for
AcnEase® sales for 2014 to exceed $1 million.

The mobile sales is growing rapidly worldwide and online
retail sales in the USA will grow from $225.5 billion in 2012 to
$434.2 billion in 2017, according to eMarketer Forrester Research
and the web will account for 11% of U.S. retail sales in 2018.

In addition, Herborium's novel all botanical acne treatment -
AcnEase® continues its rapid growth in French market and the
Company hired a French marketing and sales representative to
monetize the growing interest in a product by both e- commerce and
traditional channels.

Herborium remains very optimistic about growing its business,
sales and product awareness driven by the steady growth of the
AcnEase® brand as well as advanced preparation to commercialize its
new products: Lasting
Pleasure®and
Lasting Power® later
this year.

The Company continues its efforts to decrease costs and to
retire debt, thus increasing the Company's ability to secure
outside funding with reasonable commercial terms.

There is rising interest in Botanical Therapeutics® among
consumers as well as the financial and medical communities that
will serve as a solid foundation for the company's promising
future.

About Herborium Group, Inc.Herborium Group,
Inc., a botanical therapeutics® company that develops, license and
markets proprietary, botanical based medicinal products to
consumers and healthcare professionals. The Company business model
focuses on emerging market opportunities spearheaded by the growth
of a new market sector located between high-cost,
high-risk, ethical pharmaceuticals and commoditized classic
nutraceuticals (supplements). The Company uses clinical
validation and a proactive regulatory strategy based on the FDA
Guidance for Industry: Botanical Drug Products(FDA
Guidance 2004) to establish and maintain a differential
advantage. Herborium has secured a pipeline of botanical
ingredients based products in the areas of dermatological needs,
wellness and energy, prostate health, women's health and selected
sexual disorders resulting from cardiovascular disease, use of
anti-depressants, diabetes, surgical procedures, and other
problems. Herborium Group sells its products in the United States,
the United Kingdom, and continental Europe through a network of
distributors, specialty retailers, and e-commerce. For more
information, please visit www.herborium.com, and www.acnease.com.

Safe Harbor Statement: This release contains
forward-looking statements with respect to the results of
operations and business of Sunrise Consulting Group, Inc., which
involves risks and uncertainties. The Company's actual future
results could materially differ from those discussed.
The Company intends that such statements about the Company's future
expectations, including future revenues and earnings, and all other
forward looking statements be subject to the "Safe Harbors"
provision of the Private Securities Litigation Reform Act of
1995.

Newswire Distribution Network & Management

About Us

GlobeNewswire, a Nasdaq company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.